Daniel Louvard
Overview
Explore the profile of Daniel Louvard including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
67
Citations
4156
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Thery C, Louvard D
Mol Oncol
. 2025 Feb;
PMID: 39989268
Extracellular vesicles (EVs) have been studied for several decades and are attracting growing interest among life scientists and oncologists. Understanding the extent of diversity of their cellular origins, structure, molecular...
2.
3.
Couvreur P, Louvard D
C R Biol
. 2021 Jul;
344(1):27-42.
PMID: 34213847
This review provides an update on the different therapeutic approaches that have been used to treat SARS-CoV-2 infection, as well as, the resulting paradoxical inflammation disorders.
4.
Heuberger J, Grinat J, Kosel F, Liu L, Kunz S, Vidal R, et al.
Proc Natl Acad Sci U S A
. 2021 May;
118(22).
PMID: 34039707
Specified intestinal epithelial cells reprogram and contribute to the regeneration and renewal of the epithelium upon injury. Mutations that deregulate such renewal processes may contribute to tumorigenesis. Using intestinal organoids,...
5.
Mandati V, Del Maestro L, Dingli F, Lombard B, Loew D, Molinie N, et al.
J Biol Chem
. 2019 Jul;
294(35):12992-13005.
PMID: 31296571
Although Merlin's function as a tumor suppressor and regulator of mitogenic signaling networks such as the Ras/rac, Akt, and Hippo pathways is well-documented, in mammals as well as in insects,...
6.
Goud B, Louvard D
Med Sci (Paris)
. 2018 Feb;
34(1):63-71.
PMID: 29384098
Genetic and most likely epigenetic alterations occurring during tumor progression and metastatic process lead to a broad deregulation of major cellular functions. However, the molecular mechanisms involved are still poorly...
7.
LINGO-1 Regulates Oligodendrocyte Differentiation through the Cytoplasmic Gelsolin Signaling Pathway
Shao Z, Lee X, Huang G, Sheng G, Henderson C, Louvard D, et al.
J Neurosci
. 2017 Feb;
37(12):3127-3137.
PMID: 28193690
Differentiation and maturation of oligodendrocyte progenitor cells (OPCs) involve the assembly and disassembly of actin microfilaments. However, how actin dynamics are regulated during this process remains poorly understood. Leucine-rich repeat...
8.
Delacour D, Salomon J, Robine S, Louvard D
Nat Rev Gastroenterol Hepatol
. 2016 Feb;
13(3):161-74.
PMID: 26837713
The brush border on the apical surface of enterocytes is a highly specialized structure well-adapted for efficient digestion and nutrient transport, whilst at the same time providing a protective barrier...
9.
Couderc C, Boin A, Fuhrmann L, Vincent-Salomon A, Mandati V, Kieffer Y, et al.
Neoplasia
. 2016 Jan;
18(1):10-24.
PMID: 26806348
The Hippo signaling network is a key regulator of cell fate. In the recent years, it was shown that its implication in cancer goes well beyond the sole role of...
10.
Chanrion M, Kuperstein I, Barriere C, El Marjou F, Cohen D, Vignjevic D, et al.
Nat Commun
. 2014 Oct;
5:5005.
PMID: 25295490
Epithelial-to-mesenchymal transition-like (EMT-like) is a critical process allowing initiation of metastases during tumour progression. Here, to investigate its role in intestinal cancer, we combine computational network-based and experimental approaches to...